Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study
| Image |  |
|---|---|
| Description | scholarly article by Véronique Leblond et al published November 2018 in Haematologica |
| Author/s |
author: Stephan Stilgenbauer Robin Foà |
| Publication date | November 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |